Literature DB >> 12623188

The influence of drug type on the release profiles from Surelease-coated pellets.

Fatemeh Sadeghi1, James L Ford, Ali Rajabi-Siahboomi.   

Abstract

The release of metoclopramide hydrochloride (a water-soluble cationic drug) and diclofenac sodium (a sparingly soluble anionic drug) from pellets coated with ethylcellulose from an aqueous ethylcellulose dispersion (Surelease) at different coating loads was investigated. The release rates of each drug decreased as the coating load of Surelease increased. However, despite its lower water solubility, diclofenac sodium was released slightly faster than metoclopramide hydrochloride at equivalent coating loads. Changes in the release rates after curing were more pronounced for metoclopramide hydrochloride and the release rates of diclofenac sodium were lower than those of metoclopramide hydrochloride after curing. Differences between the release behaviour of the two drugs were probably due to an interaction between the cationic metoclopramide and the anionic ammonium oleate present in the Surelease. The slower release of metoclopramide hydrochloride may be due to an in situ formation of a poorly soluble complex of the drug and the ammonium oleate. This complex, because of its large molecular size, may diffuse more slowly through the film, causing a reduction in the release rate of metoclopramide hydrochloride. This interaction may also account for the differences in release characteristics of the drugs after curing. During curing the surfactant, due to its unstable nature in heat, may be converted to its constituent components. The interaction of drug with the surfactant was reduced as the residue of the ammonium oleate decreased during curing. However, a relatively low volume flow rate of air, and therefore, slower removal of ammonia in the modified side-vented Manesty Accela-cota 10 may also have affected the coating process of the pellets. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623188     DOI: 10.1016/s0378-5173(03)00003-6

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Microencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation.

Authors:  A Abdelbary; N A El-Gendy; A Hosny
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

2.  Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization.

Authors:  Hadi Afrasiabi Garekani; Roshanak Dolatabadi; Abbas Akhgari; Mohammad Reza Abbaspour; Fatemeh Sadeghi
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

3.  Development and In Vitro-In Vivo Evaluation of a Novel Sustained-Release Loxoprofen Pellet with Double Coating Layer.

Authors:  Dongwei Wan; Min Zhao; Jingjing Zhang; Libiao Luan
Journal:  Pharmaceutics       Date:  2019-06-05       Impact factor: 6.321

4.  Effect of Polymers on the Physicochemical Properties and Biological Performance of Fenoprofen Calcium Dihydrate-Triacetyl-β-Cyclodextrin Complex.

Authors:  Hussein O Ammar; Tarek S Makram; Shaimaa Mosallam
Journal:  Pharmaceutics       Date:  2017-07-03       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.